GH regulation of the Type 2 IGF receptor in regenerating skeletal muscle of rats.
GH enhances skeletal muscle growth, and IGF-II peptide is highly expressed during regeneration. We have therefore investigated the effect of GH administration on IGF-II binding and expression in regenerating rat skeletal muscle using the techniques of receptor autoradiography and in situ hybridisation. Notexin, a myotoxin, was injected into the right M. biceps femoris (day 0), causing affected fibres to undergo necrosis followed by rapid regeneration. Animals were administered either GH (200 micrograms/100 g body weight) or saline vehicle daily. Contralateral muscles were used as regeneration controls. GH administration during regeneration resulted in significant increases in body weight, and damaged and undamaged muscle weights (P < 0.001). IGF-II expression, which was examined in regenerating fibres, survivor fibres and undamaged fibres, varied according to tissue type (P < 0.001). Specifically, IGF-II expression in regenerating fibres was elevated relative to control and survivor fibres after day 3 (P < 0.05), with a peak on day 9 (P < 0.001). GH did not affect IGF-II message levels. 125I-IGF-II binding in regenerating muscle was examined in the same fibre types as well as in connective tissue. 125I-IGF-II binding in regenerating fibres was higher (P < 0.001) than in other tissue types on day 5. GH administration increased 125I-IGF-II binding in all damaged muscle tissues on day 5 (P < 0.001, regenerating fibres; P < 0.01, others). We believe that this shows for the first time an effect of GH on the Type 2 IGF receptor in regenerating skeletal muscle.
Kirk
S P
SP
Growth and Meat Science Group, Ruakura Agricultural Research Centre, Hamilton, New Zealand.
Whittle
M A
MA
Oldham
J M
JM
Dobbie
P M
PM
Bass
J J
JJ
D000818:Animals; D001835:Body Weight / Q000187:drug effects; D004546:Elapid Venoms / Q000494:pharmacology; D013006:Growth Hormone / Q000494:pharmacology*; D017403:In Situ Hybridization; D008297:Male; D018482:Muscle, Skeletal / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D009498:Neurotoxins / Q000494:pharmacology; D011485:Protein Binding / Q000187:drug effects; D051381:Rats; D011922:Rats, Mutant Strains; D017527:Receptor, IGF Type 2 / Q000187:drug effects* / Q000378:metabolism; D012038:Regeneration
D004546:Elapid Venoms; D009498:Neurotoxins; D017527:Receptor, IGF Type 2; C005082:notexin; D013006:Growth Hormone